News

EU funds research into causes and new therapies for multiple sclerosis The progression of multiple sclerosis (MS) can usually be slowed down with medication, but a cure is currently not possible. It is now established that Epstein-Barr virus is involved in the development of MS. However, it is not known how the pathogen triggers the [...]

The research, coordinated by Beatrice Bodega and Sergio Abrignani, has identified for the first time a new mechanism involving RNA molecules deriving from "repeated elements" of DNA: until a few years ago considered "junk DNA", they are instead fundamental for the correct function of T lymphocytes, cells at the forefront of the fight against cancer. [...]

On November 15, 2021 – Antios Therapeutics, Inc. (“Antios”), a clinical-stage biopharmaceutical company developing innovative therapies to treat and cure chronic hepatitis B virus (HBV), announced the agreement to purchase the IP rights to a novel series of fourth-generation capsid assembly modulators (CAMs) discovered and developed jointly by IRBM, Promidis/CNCCS (a subsidiary of IRBM), Istituto [...]

New research has identified potential treatment that could improve the human immune system’s ability to search out and destroy cancer cells within the body. Scientists have identified a way to restrict the activity a group of cells which regulate the immune system, which in turn can unleash other immune cells to attack tumours in cancer [...]

Merck today announced recipients of the fourth annual Grant for Oncology Innovation (GOI) awards. The three winners of this prestigious program were awarded €1 million in total to progress their research. Recipients of the 2017 GOI award are: Renata Maria Grifantini, National Institute of Molecular Genetics, Milan, Italy, for her proposal: “Novel targets of tumor-infiltrating CD4+ regulatory [...]

The European Molecular Biology Laboratory (EMBL) has assigned the 2018 Lennart Philipson Award to Raffaele De Francesco, an EMBL alumnus now head of the Virology Laboratory of INGM. Raffaele De Francesco’s work on the Hepatitis C virus (HCV) led to a medical revolution. Previously, certain chronic viral infections had been kept under control using drugs, [...]

Luca del Gobbo, delegate for University, research and Open innovation at the Lombardy Region, signed the research agreement with Promidis srl to develop innovative drugs to fight and win the hepatitis B virus. Partners in the project are Istituto Nazionale di Genetica Molecolare-INGM, San Raffaele hospital, Univerity of Milano and Policlicnico “San Matteo” in Pavia. [...]

INGM is proud to have been the host of the first "Salotto Invernizzi - INGM", on the topic "Forgeries as obstacles to change and innovation". Among others, Minister of Health Beatrice Lorenzin spoke. The discussion was moderated by Paolo Mieli. Click here to download the poster of the event. A few moments can were recorded [...]

14-16 giugno 2017 Salone Pio XII di Palazzo Schuster, Via S. Antonio, 5 – Milano Massimiliano Pagani e Raffaele De Francesco di INGM assieme a Marco Bianchi (San Raffaele), saranno gli ospiti del Meeting Annuale 2017 della Società Italiana di Biofisica e Biologia Molecolare, che avrà come tema “From Single Cells to 3D-Cell Culture”. Il [...]

UnistemDay 2017 at INGM. The long and fascinating journey of stem cells research On March 17th, for the ninth year Italy and Europe will join to this collective event to talk about science and stem cells. A whole day dedicated to the science of stem cells. Talks, seminars and events open to the public and [...]